Written Asthma Actions Plans Versus No Written Instructions In Specialty Care
The Efficacy of Written Treatment Plans in Asthma
3 other identifiers
interventional
407
1 country
1
Brief Summary
The overall goal of this randomized, controlled study is to compare a model written treatment plan with the usual care that is provided by a group of adult and pediatric pulmonologists and allergists in their practice settings. The written treatment plan is a form that allows a treatment regimen that is consistent with National Heart, Lung, and Blood Institute (NHLBI) guidelines to be conveyed to patients. Barriers to the use of written plans will be identified to better understand why some patients and physicians use written treatment plans more frequently and effectively than others. An additional goal is to assess how patients from different racial/ethnic backgrounds utilize treatments plans. Because asthma disproportionately affects African American and Latino patients, another goal of this study is to better understand if there are fundamental differences in the way patients from racial/ethnic minority groups self-manage asthma in comparison to their white counterparts. The study will also try to determine if differences exist in the way physicians care for minority patients. If there are differences, it is important to determine if the disparities can be overcome with the use of a written treatment plan form.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable asthma
Started Sep 2006
Typical duration for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2005
CompletedFirst Posted
Study publicly available on registry
September 8, 2005
CompletedStudy Start
First participant enrolled
September 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedJanuary 17, 2014
January 1, 2014
1.6 years
September 6, 2005
January 16, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Reduction in asthma symptom frequency
Using a 2-week recall period, asthma symptom frequency was measured in 3 ways: (a) the average number of days with asthma symptoms; (b) the average number of nights with symptoms; and (c) the average number of days the participant used a short-acting bronchodilator.
Measured at 3 month intervals for 12 months
Reduction in urgent, unscheduled, and emergency visits for asthma
Emergency, urgent, and unscheduled visits for asthma were combined into a single measure and assessed using a 3-month recall.
Measured at 3 month intervals for 12 months
Improved quality of life
Asthma QOL, using the Juniper Mini Asthma QOL Scale (MiniAQLQ) for adult participants and the Juniper Pediatric Asthma Caregivers QOL Questionnaire (PACQLQ) for parents, was assessed at 6 and 12-months follow-up.
Measured at 6 and 12 months
Secondary Outcomes (4)
Hospitalizations due to asthma
Measured at 3 month intervals for 12 months
Days with activity restriction
Measured at 3 month intervals for 12 months
Proportion of participants in the intervention group who are given the written asthma action plan form during the initial visit
Measured at the exit interview after the initial visit with the specialist physician
Proportion of patients in the intervention group who have the model treatment plan at the end of the follow-up period
Measured at 12 month interview
Study Arms (2)
Written Asthma Action Plan Group
EXPERIMENTALParticipants randomized to the written asthma action plan group received an asthma action plan form along with asthma education from their specialist physician.
No Written Instructions Group
NO INTERVENTIONParticipants randomized to the usual care group received no written instructions other than prescriptions from their specialist physician.
Interventions
Eligibility Criteria
You may qualify if:
- This study will enroll parents of children (ages 5-17 years) with asthma and adult patients with asthma (ages 18-80 years) who receive care at one of 4 New York Ciry medical centers (New York Presbyterian Hospital-Columbia campus, New York Presbyterian Hospital-Cornell campus, Harlem Hospital Center, and Jacobi Medical Center)
- Diagnosis of persistent asthma (as defined by NHLBI guidelines)
- All participants are new patients to the practice
- Had never been seen by a specialist physician for asthma care
- Had never received a written asthma action plan
You may not qualify if:
- Co-morbidity with conditions that affect lung function (e.g, congenital or acquired heart disease, neuromuscular disease, sickle cell disease, or chronic lung disease \[bronchopulmonary dysplasia, emphysema, or cystic fibrosis\])
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- New York Presbyterian Hospital-Cornellcollaborator
- Harlem Hospital Centercollaborator
- Jacobi Medical Centercollaborator
Study Sites (1)
Columbia University
New York, New York, 10032, United States
Related Publications (2)
Sheares BJ, Du Y, Vazquez TL, Mellins RB, Evans D. Use of written treatment plans for asthma by specialist physicians. Pediatr Pulmonol. 2007 Apr;42(4):348-56. doi: 10.1002/ppul.20586.
PMID: 17352397RESULTSheares BJ, Mellins RB, Dimango E, Serebrisky D, Zhang Y, Bye MR, Dovey ME, Nachman S, Hutchinson V, Evans D. Do Patients of Subspecialist Physicians Benefit from Written Asthma Action Plans? Am J Respir Crit Care Med. 2015 Jun 15;191(12):1374-83. doi: 10.1164/rccm.201407-1338OC.
PMID: 25867075DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Evans, PhD
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Emeritus of Clinical Sociomedical Sciences (In Pediatrics)
Study Record Dates
First Submitted
September 6, 2005
First Posted
September 8, 2005
Study Start
September 1, 2006
Primary Completion
April 1, 2008
Study Completion
July 1, 2009
Last Updated
January 17, 2014
Record last verified: 2014-01